Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$163 | -$111 | -$121 | -$105 |
| Dep. & Amort. | $3 | $10 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | -$3 |
| Stock-Based Comp. | $0 | $12 | $14 | $16 |
| Change in WC | -$21 | -$25 | $26 | -$17 |
| Other Non-Cash | $13 | -$6 | $0 | $18 |
| Operating Cash Flow | -$168 | -$120 | -$78 | -$88 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$3 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$264 | -$192 | -$174 | -$161 |
| Inv. Sales/Matur. | $305 | $251 | $302 | $301 |
| Other Inv. Act. | $0 | $0 | $0 | $3 |
| Investing Cash Flow | $40 | $56 | $127 | $141 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $1 | $1 |
| Financing Cash Flow | $0 | $2 | $1 | $1 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$127 | -$62 | $49 | $54 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $299 | $368 | $319 | $264 |
| End Cash | $172 | $306 | $368 | $319 |
| Free Cash Flow | -$168 | -$123 | -$80 | -$90 |